Utilidad diagnóstica de los marcadores tumorales en la citología del tiroides extraída por punción-aspiración con aguja fina

Gómez JM. Cáncer de tiroides. Tiroides. En: Diéguez González C, Yturriaga Matarranz R, editores. Madrid: McGraw-Hill/Interamericana; 2007. p. 253-65. Cooper, 2006, Mangement guidelines for patients with thyroid nodules and differentiated thyroid cancer, Thyroid, 16, 1, 10.1089/thy.2006.16.109 Pacini, 2006, European consensus for the management of patients with differentiated thyroid cancer of the follicular epithelium, Eur J Endocrinol, 154, 787, 10.1530/eje.1.02158 Haugen, 2002, Towards improving the utility of fine-needle aspiration biopsy for the diagnosis of thyroid tumors, Clin Endocrinol (Oxf), 56, 281, 10.1046/j.1365-2265.2002.01500.x Sahin, 2006, Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules, Clin Endocrinol (Oxf), 65, 514, 10.1111/j.1365-2265.2006.02625.x Letsas, 2006, Fine needle aspiration biopsy-RT-PCR molecular analysis of thyroid nodules: a useful preoperative diagnostic tool, Minerva Endocrinol, 31, 179 Murakawa, 2005, Expression of KIT, EGFR, HER-2 and tyrosine phosphorylation in undifferentiated thyroid carcinoma: implication for a new therepeutic approach, Pathol Intern, 55, 757, 10.1111/j.1440-1827.2005.01902.x Kebebew, 2005, ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy, Ann Surg, 242, 353, 10.1097/01.sla.0000179623.87329.6b Fryknäs, 2006, Molecular markers for discrimination of benign and malignant follicular thyroid tumors, Tumor Biol, 27, 211, 10.1159/000093056 Asa, 2005, The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid, Endocr Pathol, 16, 295, 10.1385/EP:16:4:295 Segev, 2003, Beyond the suspicious thyroid fine needle aspirate. A review, Acta Cytol, 47, 709, 10.1159/000326594 Hewnry, 1994, Thyroperoxidase immunodetection for the diagnosis of malignancy on fine-needle aspiration of thyroid nodules, World J Surg, 18, 529, 10.1007/BF00353756 De Micco, 1999, The value of thyroid peroxidase immunochemistry for preoperative fine-needle aspiration diagnosis of the follicular variant of papillary thyroid cancer, Surgery, 12, 1200, 10.1067/msy.2099.101428 Savin, 2006, The efficacy of the thyroid peroxidase marker for distinguising follicular thyroid carcinoma from follicular adenoma, Exp Oncol, 28, 70 Fuhrer, 2005, Evaluation of insulin-like growth factor II, cycloosygenase-2, ets-1 and thyroid-specific thyroglobulin mRNA expression in benign and malignant thyroid tumors, Eur J Endocrinol, 152, 785, 10.1530/eje.1.01912 Kogan, 2006, Prognostic value of the expression of thyroglobulin and oncomarkers (p53, EGFR, ret-oncogene) in different types of papillary carcinoma of the thyroid: clinicomorphological and immunohistochemical studies, Arkh Patol, 68, 8 Boi, 2006, The diagnostic value for differentiated thryoid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies, J Clin Endocrinol Metab, 91, 1364, 10.1210/jc.2005-1705 Cunha, 2007, Thyroglobulin detection in fine-needle aspirates of cervical lymph nodes: a technique for the diagnosis of metastatic differentiated thyroid cancer, Eur J Endocrinol, 157, 101, 10.1530/EJE-07-0088 Wagner, 2005, Thyrotropin receptor/thyroglobulin messenger ribonucleic acid in peripheral blood and fine-needle aspiration cytology: diagnosis synergy for detecting thyroid cancer, J Clin Endocrinol Metab, 90, 1921, 10.1210/jc.2004-1793 Wang, 2005, Expression of human telomerase reverse transcriptase in thyroid follicular neoplasms: an immunohistochemical study, Endocr Pathol, 16, 211, 10.1385/EP:16:3:211 Lerma, 2005, Telomerase activity in “suspicous” thyroid cancer, Cancer Cytophol, 105, 492, 10.1002/cncr.21380 Fernández, 1997, Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue, J Pathol, 181, 80, 10.1002/(SICI)1096-9896(199701)181:1<80::AID-PATH699>3.0.CO;2-E Collet, 2005, Galectin-3 immunodetection in follicular thryoid neoplasms: a prospective study on fine-needle aspiration samples, Br J Cancer, 93, 1175, 10.1038/sj.bjc.6602822 Ito, 2005, Galectin-3 expression in follicular tumors: and immunohistochemical study af its use as a marker of follicular carcinoma, Pathology, 37, 296, 10.1080/00313020500169545 De Matos, 2005, Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaning in the diagnosis of thyroid malignancy, Histopathology, 47, 391, 10.1111/j.1365-2559.2005.02221.x Cvejic, 2005, Galectin-3, proliferating cell nuclear antigen (PCNA) expression in papillary thyroid carcinoma, Exp Oncol, 27, 210 Aron, 2006, Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms, Indian J Pathol Microbiol, 49, 376 Rossi, 2006, Simultaneous immunohistochemical expression of HBME-1 and galectin-3 differentiates papillary carcinomas from hyperfunctioning lesions of the thyroid, Histopathology, 48, 795, 10.1111/j.1365-2559.2006.02428.x Scognamiglio, 2006, Diagnostic usefulness of HBME1, galectin-3, CK19 and CITED1 and evaluation of their expression in encapsulated lesions with questionable features of papillary thyroid carcinoma, Am J Clin Pathol, 126, 700, 10.1309/044V86JN2W3CN5YB Kim, 2006, Diagnostic utilility of galectin-3 in aspirates of thyroid follicular lesions, Acta Cytol, 50, 28, 10.1159/000325891 Mehrotra, 2004, Galectin-3 does not eliably distinguish benign from malignant thyroid neoplasms, Histopathology, 45, 493, 10.1111/j.1365-2559.2004.01978.x Cheung, 2001, Analysis of ret/PTC gene rearangements refines the fine needle aspiration diagnosis of thyroid cancer, J Clin Endocrinol Metab, 86, 2187, 10.1210/jc.86.5.2187 McIver, 2004, The PAX-8/PPAR gamma fusion oncogene as a potential therapeutic target in follicular thyroid carcinoma, Curr Drug Targets Immune Endocr Metabol Disord, 4, 221, 10.2174/1568008043339802 Dwight, 2003, Involvement of the PAX8/peroxisome proliferator-activated receptor g rearrangement in follicular thyroid tumors, J Clin Endocrinol Metab, 88, 4440, 10.1210/jc.2002-021690 Lacroix, 2004, PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malinant thyroid tissues, Eur J Endocrinol, 151, 367, 10.1530/eje.0.1510367 Lui, 2005, Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPARg fusion oncogene, Oncogene, 24, 1467, 10.1038/sj.onc.1208135 Nikiforova, 2003, RAS point mutation and PAX8PPARγ rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma, J Clin Endocrinol Metab, 88, 2318, 10.1210/jc.2002-021907 Di Cristofaro, 2006, Expression of tpo mRNA in thyroid tumors: quantitative PCR analysis and correlation with alterations of ret, Braf, ras and pax8 genes, Endocr Rel Cancer, 13, 485, 10.1677/erc.1.01164 Ito, 2005, Caveolin-1 and 14-3-3 sigma expression in follicular variant of thyroid papillary carcinoma, Pathol Res Pract, 201, 545, 10.1016/j.prp.2005.08.002 Pickett, 2005, Altered expression of cyclines and cell cycle inhibitors i papillary thryod cancer: prognostic implications, Thyroid, 15, 461, 10.1089/thy.2005.15.461 Ito, 2005, S100A9 expression is sinificantly linked to dedifferentiation of thyroid carcinma, Pathol Res Pract, 201, 545, 10.1016/j.prp.2005.08.002 Ensinger, 2006, EpCAM overexpression in thyroid carcinomas: a histopathological study of 121 cases, Immunother, 29, 569, 10.1097/01.cji.0000211303.52503.da Chandan, 2006, The role of immunolocalization of CD57 and GLUT-1 in cell bloks in fine-needle aspiration diagnosis of papillary thyroid carcinoma, Cancer Cytopathol, 108, 331, 10.1002/cncr.22172 Mehrotra, 2006, Mcm-2 and Ki-67 have limited potential in preoperative diagnosis of thyroid malignancy, Laryngoscope, 116, 1434, 10.1097/01.mlg.0000225931.59644.93 Kebebew, 2005, ECM1 and TMPRSS4 are diagnostic markers of malignant thyrod neoplasms and improve the accuracy of fine needle aspiration biopsy, Ann Surg, 242, 353, 10.1097/01.sla.0000179623.87329.6b Cerutti, 2006, Diagnosis of suspicious thyroid nodules using four protein biomarkers, Clin Cancer Res, 12, 3311, 10.1158/1078-0432.CCR-05-2226 Finley, 2005, Advancing the molecular diagnosis of thyroid nodules: defining benign lesions by molecular profiling, Thyroid, 15, 562, 10.1089/thy.2005.15.562 Torres-Cabala, 2006, Proteomic identification of new biomarkers and application in thyroid cytology, Acta Cytol, 50, 518, 10.1159/000326006